CTS Corp. 10-Q Summary: Quarter Ended October 3, 2010
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for CTS Corporation, a global manufacturer of components, sensors, and electronic manufacturing solutions serving automotive, communications, defense, aerospace, and medical markets. The report covers the three and nine-month periods ended October 3, 2010, compared to the same periods in 2009.
Key Financial Metrics
| Metric | Q3 2010 | Q3 2009 | 9M 2010 | 9M 2009 |
|---|---|---|---|---|
| Net Sales | $139.4M | $126.6M | $407.6M | $365.1M |
| Gross Margin % | 21.5% | 20.7% | 22.3% | 18.6% |
| Operating Earnings | $7.8M | $6.3M | $21.9M | ($26.1M) |
| Net Earnings | $6.9M | $4.5M | $17.2M | ($38.2M) |
| Diluted EPS | $0.20 | $0.13 | $0.50 | ($1.13) |
| Cash & Equivalents | $73.0M (Oct 3, 2010) | |||
| Long-Term Debt | $77.1M (Oct 3, 2010) | |||
| Operating Cash Flow (9M) | $8.1M (2010) vs $34.1M (2009) |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 10.1% in Q3 and 11.6% year-to-date (YTD), driven primarily by a 28.6% surge in the Components and Sensors segment (automotive and electronic components) offset by a 4.4% decline in the EMS segment.
- Profitability Turnaround: The company returned to profitability in 2010. The 9M 2009 results included a $33.2M goodwill impairment charge and $2.2M in restructuring costs, which were absent in 2010.
- Margin Expansion: Gross margin improved due to a favorable sales mix shift toward the higher-margin Components and Sensors segment and better absorption of fixed costs.
- Expense Increases: R&D expenses rose significantly ($1.7M in Q3, $3.8M YTD) to support new product development. SG&A expenses increased slightly but remained efficient relative to sales growth.
- Debt Levels: Long-term debt increased from $50.4M to $77.1M to fund working capital requirements associated with higher sales volumes.
Guidance, Outlook, and Risks
- Guidance: Management raised full-year 2010 diluted EPS guidance to $0.60–$0.65 (previously $0.55–$0.62). Full-year sales are estimated to increase 10%–15% over 2009.
- Toyota Recall Contingency: CTS manufactures accelerator pedals for Toyota. Following a 2010 recall of 2.3M vehicles, CTS is a co-defendant in litigation. However, an indemnification agreement with Toyota limits CTS's liability to amounts collectible from its insurers. Management states costs to date are immaterial.
- Segment Performance: The EMS segment reported an operating loss of $2.8M for the first nine months of 2010, primarily due to lower sales in defense, aerospace, and computer markets (including end-of-life product sales to Hewlett-Packard).
- Liquidity: The company maintains a $100M revolving credit facility (expandable to $150M) with $20.1M available as of October 3, 2010. All debt covenants were met.
Investor Verification Checklist
- Toyota Indemnification Scope: Verify the specific limitations of the indemnification agreement regarding government investigations and potential negligence claims.
- EMS Segment Recovery: Monitor the trajectory of the EMS segment, which is currently operating at a loss due to cyclical declines in defense and computer markets.
- Working Capital Trends: Review the continued increase in inventory and accounts receivable to ensure they align with sales growth and do not signal collection or obsolescence issues.
- Debt Covenants: Confirm ongoing compliance with leverage and fixed charge coverage ratios as debt levels have risen to support operations.
- R&D ROI: Assess whether the increased R&D spending ($14.0M YTD) translates into sustained revenue growth in the Components and Sensors segment.